Correlation Engine 2.0
Clear Search sequence regions

  • ACTA2 (10)
  • adenocarcinoma (1)
  • Bcl 2 (2)
  • cancer (6)
  • cell movement (1)
  • colon adenocarcinoma (1)
  • humans (2)
  • micrornas (2)
  • MMP 2 (2)
  • MMP 9 (2)
  • nuclear antigen (2)
  • pcna (2)
  • rna (6)
  • western blot (1)
  • Sizes of these terms reflect their relevance to your search.

    The role of long non-coding RNA ACTA2 antisense RNA 1 (LncRNA ACTA2-AS1) in colorectal cancer (CRC) was awaited to be elucidated. Clinical specimen and data on ACTA2-AS1 expression in colon adenocarcinoma (COAD) were collected, followed by in situ hybridization. Transfected CRC cell viability, proliferation, migration, and invasion were determined with Cell Counting Kit-8, colony formation, Scratch, and Transwell assays, respectively. Relative expressions of ACTA2-AS1, PCNA, Bcl-2, MMP-2 and MMP-9 were quantified by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot. ACTA2-AS1 expression was downregulated in CRC. Overexpressed ACTA2-AS1 repressed the cell viability, proliferation, migration and invasion, increased cleaved caspase-3 level yet decreased PCNA, Bcl-2, MMP-2 and MMP-9 levels. ACTA2-AS1 silencing, however, did oppositely. Collectively, ACTA2-AS1 inhibits the viability, proliferation, migration and invasion of CRC cells to effectively suppress the progression of CRC. Copyright © 2022. Published by Elsevier Ltd.


    Xiaoping Wu, Qiujie Pang, Fuxiang Zhi, Xiaohong Mao, Yingbin Hu. Overexpression of long non-coding RNA ACTA2-AS1 inhibits the viability, proliferation, migration and invasion of colorectal cancer cells. Tissue & cell. 2022 Jun;76:101769

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 35325674

    View Full Text